Monoamine Oxidase Contributes to Valvular Oxidative Stress: A Prospective Observational Pilot Study in Patients with Severe Mitral Regurgitation
Authors:
- Raluca ȘoșdeanRȘRaluca Șoșdean
- Maria D. DănilăMDMaria D. Dănilă
- Loredana N. IonicăLILoredana N. Ionică
- Alexandru S. PescariuAPAlexandru S. Pescariu
- Monica MirceaMMMonica Mircea
- Adina IonacAdina Ionac
- Cristian MornoșCMCristian Mornoș
- Constantin T. LucaCLConstantin T. Luca
- Horea B. FeierHFHorea B. Feier
- Danina M. MunteanDanina M. Muntean
- Adrian SturzaASAdrian Sturza
Open Access
- 25 September 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (19) , 10307
Abstract
Monoamine oxidases (MAOs), mitochondrial enzymes that constantly produce hydrogen peroxide (H2O2) as a byproduct of their activity, have been recently acknowledged as contributors to oxidative stress in cardiometabolic pathologies. The present study aimed to assess whether MAOs are mediators of valvular oxidative stress and interact in vitro with angiotensin 2 (ANG2) to mimic the activation of the renin–angiotensin system. To this aim, valvular tissue samples were harvested from 30 patients diagnosed with severe primary mitral regurgitation and indication for surgical repair. Their reactive oxygen species (ROS) levels were assessed by means of a ferrous oxidation xylenol orange (FOX) assay, while MAO expression was assessed by immune fluorescence (protein) and qRT-PCR (mRNA). The experiments were performed using native valvular tissue acutely incubated or not with angiotensin 2 (ANG2), MAO inhibitors (MAOI) and the angiotensin receptor blocker, irbesartan (Irb). Correlations between oxidative stress and echocardiographic parameters were also analyzed. Ex vivo incubation with ANG2 increased MAO-A and -B expression and ROS generation. The level of valvular oxidative stress was negatively correlated with the left ventricular ejection fraction. MAOI and Irb reduced valvular H2O2. production. In conclusion, both MAO isoforms are expressed in pathological human mitral valves and contribute to local oxidative stress and ventricular functional impairment and can be modulated by the local renin–angiotensin system.Keywords
Funding Information
- “Victor Babes” University of Medicine and Pharmacy
This publication has 61 references indexed in Scilit:
- Monoamine oxidase mediated oxidative stress: a potential molecular and biochemical crux in the pathogenesis of obesityMolecular Biology Reports, 2023
- Recent advances on the role of monoamine oxidases in cardiac pathophysiologyBasic Research in Cardiology, 2023
- Metformin and empagliflozin modulate monoamine oxidase-related oxidative stress and improve vascular function in human mammary arteriesMolecular and Cellular Biochemistry, 2022
- Monoamine Oxidase, Obesity and Related Comorbidities: Discovering Bonds2021
- Interrelationship between renin-angiotensin-aldosterone system and oxidative stress in chronic heart failure patients with or without renal impairmentBiomedicine & Pharmacotherapy, 2021
- Isolated Mitral Valve Surgery: The Society of Thoracic Surgeons Adult Cardiac Surgery Database AnalysisThe Annals of Thoracic Surgery, 2018
- Platelet activation and arterial peripheral serotonin turnover in cardiac remodeling associated to aortic stenosisAmerican Journal of Hematology, 2014
- Monoamine oxidases (MAO) in the pathogenesis of heart failure and ischemia/reperfusion injuryBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- Structural properties of human monoamine oxidases A and B2011
- Methods for detection and measurement of hydrogen peroxide inside and outside of cellsMolecules and Cells, 2010